1345 mTFF2-MSA (mTNX-1700) suppresses tumor growth and increases survival in anti-PD-1 treated CT26.wt subcutaneous and CT26-Luciferase orthotopic syngeneic colorectal cancer models by targeting MDSCs

• Grace Zhao,
• Timothy C Wang,
• Mingfa Zang,
• Jin Qian,
• Bruce L Daugherty,
• Seth Lederman,
• Rebecca J Boohaker,
• Rebecca Johnstone,
• Karr Stinson

Affiliations

Grace Zhao

3Crown Bioscience, San Diego, CA, USA

Timothy C Wang

3Columbia University, New York, NY, USA

Mingfa Zang

2Crown Bioscience, San Diego, CA, USA

Jin Qian

3Columbia University, New York, NY, USA

Bruce L Daugherty

1Tonix Pharmaceuticals, Inc, Chatham, NJ, USA

Seth Lederman

1Tonix Pharmaceuticals, Inc, Chatham, NJ, USA

Rebecca J Boohaker

2Southern Research, Birmingham, AL, USA

Rebecca Johnstone

2Southern Research, Birmingham, AL, USA

Karr Stinson

2Southern Research, Birmingham, AL, USA